logo
ScreenersREIT EarningsREIT SectorsMarketplaceLearn
Logo

MiMedx Group, Inc.

MDXG

MiMedx Group, Inc. develops and distributes placental tissue allografts for various sectors of healthcare. It processes the human placental tissues utilizing its patented and proprietary PURION process to produce allografts that retains the tissue's inherent biological properties and regulatory proteins. The company's patented and proprietary processing method employs aseptic processing techniquesā€¦ read more

Healthcare

Biotechnology

15 years

USD

Exclusive to Premium users

Price

per share adjusted in USD

$7.11

Price

-0.56%

-$0.04

$7.15

Previous Close

$7.18

Open

Premium

52w Discount
Market Cap

$1.052b

Small

Price/Earnings

33.9x

Premium

3y Avg

Premium

5y Avg

Financials Overview

Key metrics over the past few years

-

EBITDA Margin

-

Net Profit Margin

-

Free Cash Flow Margin
Revenue

$363.774m

-

1y CAGR

-

3y CAGR

-

5y CAGR
Earnings

$32.174m

-

1y CAGR

-

3y CAGR

-

5y CAGR
EPS

$0.21

-

1y CAGR

-

3y CAGR

-

5y CAGR
Book Value

$216.624m

$291.109m

Assets

$74.485m

Liabilities

$18.461m

Debt
Debt to Assets

6.3%

0.4x

Debt to EBITDA
Free Cash Flow

$61.342m

-

1y CAGR

-

3y CAGR

-

5y CAGR

Financial Reports

Earnings and other important metrics. Amounts in USD.
No items found.
Press Releases
Statements and updates from the company
ā†‘ TopSummaryPriceFinancialsPress Releases
logo
About usFAQ
All the information presented is collected from official and public documents such as: Quarterly and Annual Reports, 10-K (US), Information Form (Canada), Presentations and the Investor Relations (IR) section of the company's website.
The data displayed by alreits.com is solely for informational purposes, we do not recommend the buying, holding or selling of any of the stocks on the website. If you have no experience in the stock market, please talk to your personal licensed investment advisor before making any decisions.